|
|
|
26 February, 2013
|
| In this Issue |
Is National Drug Pricing Freedom Reaching its Expiry Date?
For more than fifty years the basic EU rules about medicines have been clear. Each member country is free to decide the prices that medicines are sold at in its territory, and what reimbursement should be provided for it. But an observer of the European Parliament discussions in February wouldn’t think so ...Read more |
Packaging: UK and US Regulators Call for Better Patient Information
Often, the patient himself has been lost in the regulations surrounding patient information leaflets. The UK’s MHRA and the US’s Office of the Inspector General have now stepped up to try and fix this through a mix of regulatory changes and better communication with manufacturers ... Read more |
Rethinking Product Lifecycle Management
Pharma professionals adopting the "Drug Life Optimization" approach can wrest more value through strategies that build and promote a drug's brand franchise through its entire lifespan, not simply the product lifecycle ... Read more |
Vote for 2013’s Emerging Pharma Leaders
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input! Tell us who you think should receive Pharmaceutical Executive's Emerging Pharma Leadership Award. Fill out a nomination today ... Read more
|
|
|
|
How do you think the reputation of the pharmaceutical industry has changed in recent years?
